Literature DB >> 15744589

Transient respiratory failure possibly associated to imatinib.

C Lengerke, T Brümmendorf, U Herrlinger, M Horger, L Kanz, J T Hartmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15744589     DOI： 10.1007/s10637-005-5858-5

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  7 in total

1.  The incidence of complications associated with local anesthesia in dentistry.

Authors:  M Daubländer; R Müller; M D Lipp
Journal:  Anesth Prog       Date:  1997

2.  Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.

Authors:  B E Plaat; H Hollema; W M Molenaar; G H Torn Broers; J Pijpe; M F Mastik; H J Hoekstra; E van den Berg; R J Scheper; W T van der Graaf
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

3.  Cerebral oedema as a possible complication of treatment with imatinib.

Authors:  M Ebnöether; J Stentoft; J Ford; L Buhl; A Gratwohl
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

4.  Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.

Authors:  A T van Oosterom; I Judson; J Verweij; S Stroobants; E Donato di Paola; S Dimitrijevic; M Martens; A Webb; R Sciot; M Van Glabbeke; S Silberman; O S Nielsen
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

Review 5.  Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.

Authors:  Markku Miettinen; Wa'el El-Rifai; Leslie H L Sobin; Jerzy Lasota
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

6.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

7.  Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Authors:  Michael C Heinrich; Christopher L Corless; George D Demetri; Charles D Blanke; Margaret von Mehren; Heikki Joensuu; Laura S McGreevey; Chang-Jie Chen; Annick D Van den Abbeele; Brian J Druker; Beate Kiese; Burton Eisenberg; Peter J Roberts; Samuel Singer; Christopher D M Fletcher; Sandra Silberman; Sasa Dimitrijevic; Jonathan A Fletcher
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.